Humoral Immune Response to Orientia tsutsugamushi Infection: Recent Research Findings and Future Studies

Abstract

Orientia tsutsugamushi (Ot), an intracellular bacterium in the family Rickettsiaceae, is the etiological agent of scrub typhus. Understanding of the immunologic responses to Ot infection, particularly immunity after infection, has remained a major knowledge gap. Although anti-Ot IgG appears to be short-lived in infected humans, recent studies have reported autoreactive IgM antibodies in people with scrub typhus, including antibodies reactive to nuclear components, DNA, and platelets. However, mechanistic studies of B cell responses in the secondary lymphoid organs of infected humans are severely lacking. This article highlights feasible methods to investigate important aspects of humoral immunity, and avenues to obtain samples from post-mortem and ante-mortemOt-infected people. A pioneer study identified that serum passive transfer could protect against homologous Ot challenge. Studies comparing humoral immune responses to Ot Karp versus Gilliam strains have revealed impaired B cell and germinal center (GC) responses during severe, but not self-limiting, infection in C57BL/6 mice. Further studies are needed, particularly in people with scrub typhus, to help understand and define deficiencies in the acute B cell response and long-lived humoral immunity.

Keywords

Scrub typhus / humoral immunity / B cell / germinal center / splenic architecture / Orientia tsutsugamushi

References

[1] Saunders JP, Brown GW, Shirai A, Huxsoll DL. The longevity of antibody to Rickettsia tsutsugamushi in patients with confirmed scrub typhus . Trans R Soc Trop Med Hyg. 1980; 74(2): 253-257.

[2] Ha NY, Kim Y, Min CK, Kim HI, Yen NTH, Choi MS, et al. Longevity of antibody and T-cell responses against outer membrane antigens of Orientia tsutsugamushi in scrub typhus patients . Emerg Microbes Infect. 2017; 6(12): e116.

[3] Schmidt WP, Devamani CS, Rose W, Alexander N, Prakash JAJ. Antibody response following scrub typhus infection: clinical cohort study. Trop Med Int Health. 2019; 24(12): 1455-1464.

[4] Devamani CS, Prakash JAJ, Alexander N, Suzuki M, Schmidt WP. Hospitalisations and outpatient visits for undifferentiated fever attributable to scrub typhus in rural South India: retrospective cohort and nested case-control study. PLoS Negl Trop Dis. 2019; 13(2): e0007160.

[5] Trowbridge P, Divya P, Premkumar PS, Varghese GM. Prevalence and risk factors for scrub typhus in South India. Trop Med Int Health. 2017; 22(5): 576-582.

[6] Bonell A, Lubell Y, Newton PN, Crump JA, Paris DH. Estimating the burden of scrub typhus: a systematic review. PLoS Negl Trop Dis. 2017; 11(9): e0005838.

[7] Devamani CS, Prakash JAJ, Alexander N, Stone W, Gunasekaran K, Rose W, et al. High initial IgG antibody levels against Orientia tsutsugamushi are associated with an increased risk of severe scrub typhus infection . PLoS Negl Trop Dis. 2021; 15(3): e0009283.

[8] You H, Song J, Kim S, Oh SM, Hwang JH, Hwang JH, et al. Scrub typhus association with autoimmune biomarkers and clinical implications. PLoS Negl Trop Dis. 2025; 19(1): e0012766.

[9] Chowdhary PK, Agrawal RK, Kumar S, Kale SA, Kumar V. Rare and unusual presentation as immune thrombocytopenic purpura in scrub typhus complicated by meningitis and acute kidney injury. Indian J Crit Care Med. 2022; 26(6): 748-751.

[10] Auxilia J, Daniel NJ, Rajan N. Secondary immune thrombocytopenic purpura: an unusual complication of scrub typhus. J Current Res Sci Med. 2025; 11(1): 76-78.

[11] Kim W, Zhou JQ, Horvath SC, Schmitz AJ, Sturtz AJ, Lei T, et al. Germinal centre-driven maturation of B cell response to mRNA vaccination. Nature. 2022; 604(7904): 141-145.

[12] Mudd PA, Minervina AA, Pogorelyy MV, Turner JS, Kim W, Kalaidina E, et al. SARS-CoV-2 mRNA vaccination elicits a robust and persistent T follicular helper cell response in humans. Cell. 2022; 185(4): 603-613.e15.

[13] Sakharkar M, Rappazzo CG, Wieland-Alter WF, Hsieh CL, Wrapp D, Esterman ES, et al. Prolonged evolution of the human B cell response to SARS-CoV-2 infection. Sci Immunol. 2021; 6(56): eabg6916.

[14] Turner JS, O’Halloran JA, Kalaidina E, Kim W, Schmitz AJ, Zhou JQ, et al. SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses. Nature. 2021; 596(7870): 109-113.

[15] Kaneko N, Kuo HH, Boucau J, Farmer JR, Allard-Chamard H, Mahajan VS, et al. Loss of Bcl-6-expressing T follicular helper cells and germinal centers in COVID-19. Cell. 2020; 183(1): 143-157.e13.

[16] Gonzales C, Liang Y, Thiriot J, Wang H, Villacreses D, Sun J, et al. Unique B cell and germinal center responses in mice with severe versus mild Orientia tsutsugamushi infection . bioRxiv. 2025. https://doi.org/10.1101/2025.03.27.645674

[17] Soong L, Mendell NL, Olano JP, Rockx-Brouwer D, Xu G, Goez-Rivillas Y, et al. An intradermal inoculation mouse model for immunological investigations of acute scrub typhus and persistent infection. PLoS Negl Trop Dis. 2016; 10(8): e0004884.

[18] Thiriot JD, Liang Y, Gonzales C, Sun J, Yu X, Soong L. Differential cellular immune responses against Orientia tsutsugamushi Karp and Gilliam strains following acute infection in mice . PLoS Negl Trop Dis. 2023; 17(12): e0011445.

[19] Shelite TR, Saito TB, Mendell NL, Gong B, Xu G, Soong L, et al. Hematogenously disseminated Orientia tsutsugamushi-infected murine model of scrub typhus [corrected] . PLoS Negl Trop Dis. 2014; 8(7): e2966.

[20] Shirai A, Catanzaro PJ, Phillips SM, Osterman JV. Host defenses in experimental scrub typhus: role of cellular immunity in heterologous protection. Infect Immun. 1976; 14(1): 39-46.

[21] Topping NH. Tsutsugamushi disease (scrub typhus); the effects of an immune rabbit serum in experimentally infected mice. Public Health Rep. 1945; 60: 1215-1220.

[22] Seong SY, Huh MS, Jang WJ, Park SG, Kim JG, Woo SG, et al. Induction of homologous immune response to Rickettsia tsutsugamushi Boryong with a partial 56-kilodalton recombinant antigen fused with the maltose-binding protein MBP-Bor56 . Infect Immun. 1997; 65(4): 1541-1545.

[23] Rikihisa Y, Ito S. Effect of antibody on entry of Rickettsia tsutsugamushi into polymorphonuclear leukocyte cytoplasm . Infect Immun. 1983; 39(2): 928-938.

[24] Nacy CA, Osterman JV. Host defenses in experimental scrub typhus: role of normal and activated macrophages. Infect Immun. 1979; 26(2): 744-750.

[25] Gonzales C, Liang Y, Fisher J, Card G, Sun J, Soong L. Alterations in germinal center formation and B cell activation during severe Orientia tsutsugamushi infection in mice . PLoS Negl Trop Dis. 2023; 17(5): e0011090.

[26] Liang Y, Wang H, Sun K, Sun J, Soong L. Lack of the IFN-γ signal leads to lethal Orientia tsutsugamushi infection in mice with skin eschar lesions . PLoS Pathog. 2024; 20(5): e1012020.

[27] Biram A, Liu J, Hezroni H, Davidzohn N, Schmiedel D, Khatib-Massalha E, et al. Bacterial infection disrupts established germinal center reactions through monocyte recruitment and impaired metabolic adaptation. Immunity. 2022; 55(3): 442-458.e8.

[28] Walker DH, Mendell NL. A scrub typhus vaccine presents a challenging unmet need. NPJ Vaccines. 2023; 8(1): 11.